Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 314140229 approvals1 trials

RPbio Inc.

Official website

Founded in 2016 and listed on the KOSDAQ in 2022, RPbio is a soft-capsule OEM/ODM contract manufacturer for pharmaceuticals and health functional foods.

As of 2026-10-11, RPbio Inc. has 229 Korean MFDS drug approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • OTC products (cold medicine, painkillers, vitamins/minerals, circulation improvers)OTC soft capsule
  • New NeosolSolubilization technology for poorly soluble drugs
  • Health functional foods (omega-3, lutein-zeaxanthin, vitamin D, etc.)Health functional food
  • New NeogelCapsule leak-prevention technology (up to 36-month shelf life)

Regulatory approvals

data.go.kr

229 Korean MFDS drug approvals · 1997–2026

  • MFDS drugColstop N Soft Cap.2026-08-06
    Drug · OTC · Notification202602279
  • MFDS drugFlu Cold Soft Cap.2026-08-03
    Drug · OTC · Notification202602239
  • MFDS drugFINE-SPEED Soft Capsule2026-07-08
    Drug · OTC · Notification202601979
  • MFDS drugMgpick Soft capsule2026-06-24
    Drug · OTC · Notification202601795
  • MFDS drugFour Eve Balance Soft Cap.2026-06-10
    Drug · OTC · Notification202601653
  • MFDS drugMGPlus 4X soft cap.2026-05-19
    Drug · OTC · Notification202601449
  • MFDS drugChame Cold soft capsule2026-04-20
    Drug · OTC · Notification202601126
  • MFDS drugChame Nose Soft capsule2026-04-20
    Drug · OTC · Notification202601135
  • MFDS drugChame Cough Soft capsule2026-04-20
    Drug · OTC · Notification202601136
  • MFDS drugEve Ssen Dual Soft Cap.2026-04-13
    Drug · OTC · Notification202601042
  • MFDS drugRP Cucurbit soft capsule(Cucurbit Semen Oil Extract(15~251))2026-04-01
    Drug · OTC · Notification202600915
  • MFDS drugCarolB Nose Plus Soft Cap.2026-03-13
    Drug · OTC · Notification202600754
Show 68 more
  • MFDS drugCarolB Cold Plus Soft Cap.2026-03-09
    Drug · OTC · Notification202600695
  • MFDS drugMagpo Soft Cap.2026-01-28
    Drug · OTC · Notification202600257
  • MFDS drugI'M FINE-COLD Soft Cap.2025-12-26
    Drug · OTC · Notification202503395
  • MFDS drugNosefree Strong Soft Cap.2025-12-17
    Drug · OTC · Notification202503301
  • MFDS drugEve B Dual Soft Cap.2025-12-10
    Drug · OTC · Notification202503227
  • MFDS drugEve Dual Soft Cap.2025-12-10
    Drug · OTC · Notification202503228
  • MFDS drugVitacol Soft Cap.2025-12-05
    Drug · OTC · Notification202503178
  • MFDS drugCarolB Cough Plus Soft Cap.2025-11-28
    Drug · OTC · Notification202503119
  • MFDS drugEye Max CMC Eye Drops 1%(Carboxymethylcellulose Sodium)(Single use)2025-07-22
    Drug · OTC · Notification202501850
  • MFDS drugEye Max Trehalose Eye Drops(Trehalose Hydrate)(Single use)2025-07-21
    Drug · OTC · Notification202501834
  • MFDS drugWellbeing Multivita S Soft Cap.Revoked2025-06-26
    Drug · OTC · Notification202501580
  • MFDS drugCotenvita Q Soft Cap.2025-05-19
    Drug · OTC · Notification202501211
  • MFDS drugMagnetit Soft Cap.Revoked2025-05-13
    Drug · OTC · Notification202501162
  • MFDS drugVitaminophen Strong Soft Cap.2025-04-23
    Drug · OTC · Notification202500975
  • MFDS drugPharmsvitaA Soft Cap.Revoked2025-04-23
    Drug · OTC · Notification202500972
  • MFDS drugCo10 Power gold Soft Cap.Revoked2025-04-10
    Drug · OTC · Notification202500849
  • MFDS drugCoQhealthytamingold Soft Cap.2025-04-08
    Drug · OTC · Notification202500823
  • MFDS drugMageupoten soft cap.Revoked2025-01-24
    Drug · OTC · Notification202500193
  • MFDS drugSunDtamin soft cap.2025-01-20
    Drug · OTC · Notification202500145
  • MFDS drugTaewoori Soft Cap.Revoked2024-09-02
    Drug · OTC · Notification202402135
  • MFDS drugBoost Jelly2024-07-30
    Drug · OTC · Notification202401840
  • MFDS drugColgam Night Soft Cap.Revoked2024-04-23
    Drug · OTC · Notification202400941
  • MFDS drugNunetteune soft cap.2024-04-01
    Drug · OTC · Notification202400727
  • MFDS drugCo10 Power forte Soft Cap.Revoked2023-09-27
    Drug · OTC · Notification202302851
  • MFDS drugRP-D 1ug soft capsule2023-07-31
    Drug · OTC · Notification202302307
  • MFDS drugRP-D 0.5ug soft capsule2023-07-31
    Drug · OTC · Notification202302308
  • MFDS drugAcetwopen Soft Cap.Revoked2023-07-03
    Drug · OTC · Notification202302028
  • MFDS drugChewED Soft capsuleRevoked2023-04-21
    Drug · OTC · Notification202301319
  • MFDS drugTuk-tuk 6 Cough Soft Cap.Revoked2023-04-14
    Drug · OTC · Notification202301247
  • MFDS drugtuk-tuk 6 cold Soft Cap.Revoked2023-04-14
    Drug · OTC · Notification202301249
  • MFDS drugTuk-tuk Cough Soft Cap.Revoked2023-04-04
    Drug · OTC · Notification202301134
  • MFDS drugTuk-tuk Cold Soft Cap.Revoked2023-04-04
    Drug · OTC · Notification202301135
  • MFDS drugD Q Pen Max Tab. 500mg.2023-03-31
    Drug · OTC · Notification202301097
  • MFDS drugchewchew cough soft cap.Revoked2022-09-16
    Drug · OTC · Notification202203588
  • MFDS drugThank you enteric Soft Cap.Revoked2022-07-14
    Drug · OTC · Notification202202900
  • MFDS drugClear Cold Nose Soft Cap.Revoked2022-06-22
    Drug · OTC · Notification202202602
  • MFDS drugNose-R Soft Cap.2022-06-08
    Drug · OTC · Approval202202380
  • MFDS drugConcept Chunwangbosimdan Sol.2022-05-10
    Drug · OTC · Notification202201886
  • MFDS drugConcept Maekmundongtang Granule2022-05-04
    Drug · OTC · Notification202201842
  • MFDS drugSoon Galgeuntang A Soln.2022-05-03
    Drug · OTC · Notification202201816
  • MFDS drugMiricough Power soft cap.2022-05-02
    Drug · OTC · Notification202201771
  • MFDS drugChew Chew Nose Soft Cap.Revoked2022-04-14
    Drug · OTC · Notification202201560
  • MFDS drugBmega Soft Cap. 300mg (Ethyl Icosapentate)2022-02-21
    Drug · Prescription · Approval202200791
  • MFDS drugD-Q-pain max Soft Cap.Revoked2022-02-21
    Drug · OTC · Notification202200793
  • MFDS drugBenfoduophen Soft Cap.Revoked2022-02-03
    Drug · OTC · Notification202200524
  • MFDS drugPower Gold Multi Vitamin Soft Cap.Revoked2022-01-27
    Drug · OTC · Notification202200436
  • MFDS drugConcept Sayeogsan PillRevoked2022-01-27
    Drug · OTC · Notification202200466
  • MFDS drugConcept Wiryeongtang Granule2022-01-20
    Drug · OTC · Notification202200349
  • MFDS drugWellime Cap.Revoked2021-11-15
    Drug · OTC · Notification202107460
  • MFDS drugConcept Banhasasimtang Granule2021-11-10
    Drug · OTC · Notification202107392
  • MFDS drugFolxetin Cap. 10mg(fluoxeine hydrochloride)2021-10-19
    Drug · Prescription · Approval202107002
  • MFDS drugSoon Ssanghwatang Soln.2021-10-13
    Drug · OTC · Notification202106886
  • MFDS drugSoon Socheongryongtang Soln.2021-10-07
    Drug · OTC · Notification202106802
  • MFDS drugSoon Samsocheon Soln.2021-10-07
    Drug · OTC · Notification202106808
  • MFDS drugSoon Galgeuntang Soln.2021-10-07
    Drug · OTC · Notification202106809
  • MFDS drugEcaS Tab.Revoked2021-10-06
    Drug · OTC · Notification202106745
  • MFDS drugFolxetin Cap. 20mg(fluoxeine hydrochloride)Revoked2021-09-29
    Drug · Prescription · Approval202106679
  • MFDS drugVitaminophen Soft Cap.Revoked2021-09-10
    Drug · OTC · Notification202106496
  • MFDS drugNument Mg Max Soft Cap.2021-07-19
    Drug · OTC · Notification202105432
  • MFDS drugConcept Chungpyetang Granule2021-07-05
    Drug · OTC · Notification202105065
  • MFDS drugConcept Galgeuntang Granule2021-05-03
    Drug · OTC · Notification202103609
  • MFDS drugConcept Socheongryongtang Granule2021-05-03
    Drug · OTC · Notification202103615
  • MFDS drugConcept Eunkyosan Cap.2021-04-29
    Drug · OTC · Notification202103495
  • MFDS drugConcept Baenongsangeuptang Cap.2021-04-29
    Drug · OTC · Notification202103497
  • MFDS drugPage Soft Cap.2021-04-02
    Drug · OTC · Notification202102875
  • MFDS drugGast-Q Tab.2021-03-12
    Drug · OTC · Notification202102261
  • MFDS drugDentiten Cap.Revoked2021-03-12
    Drug · OTC · Notification202102262
  • MFDS drugHardyQ Cold Soft Cap.2021-03-09
    Drug · OTC · Notification202102171

Showing the 80 most recent of 229 records.

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2019 (Bioequivalence 1)

  • Bioequivalence알피콜린알포세레이트2019-07-08

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

연질 제형 고도화 및 신규 제형 개발 · The Gwanggyo R&D center advances soft-capsule formulation, develops new formulations, and improves existing products.

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 19 more patents

AI reads

MAA server logs · IP-verified
77
Times AI engines pulled RPbio Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

76
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 1
Last 7 days
59
live 1
Last 30 days
77
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot70
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for RPbio Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition